Literature DB >> 1634525

Characterization of the multisubunit cleavage-polyadenylation specificity factor from calf thymus.

K G Murthy1, J L Manley.   

Abstract

Cleavage-polyadenylation specificity factor (CPSF) is one of five separable factors known to be required for 3' cleavage and polyadenylation of mRNA precursors in vitro. Previous studies have shown that the cleavage and poly(A) addition reactions can be uncoupled in vitro and have suggested that CPSF may be the only factor essential for both of these subreactions. Here we report the purification of CPSF to near homogeneity from calf thymus and show that the purified factor contains three polypeptides of 165, 105, and 70 kDa. These polypeptides cosediment precisely with CPSF activity, which has a sedimentation coefficient of 11.5 S. Consistent with previous reports from our laboratory, purified CPSF does not contain a detectable RNA component, indicating that it is a multisubunit protein and not a small nuclear ribonucleoprotein. Extensively purified bovine CPSF can function with human poly(A) polymerase to bring about AAUAAA-dependent poly(A) addition or with human cleavage factors to catalyze accurate 3' cleavage of a pre-mRNA substrate. UV cross-linking and gel retention analyses demonstrate that highly purified CPSF interacts with one of these cleavage factors, the multisubunit cleavage-stimulation factor, to facilitate stable binding of both to an AAUAAA-containing pre-mRNA. Likewise, evidence is presented indicating that poly(A) polymerase and CPSF can interact directly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1634525

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  Utilization of splicing elements and polyadenylation signal elements in the coupling of polyadenylation and last-intron removal.

Authors:  C Cooke; H Hans; J C Alwine
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Recruitment of a basal polyadenylation factor by the upstream sequence element of the human lamin B2 polyadenylation signal.

Authors:  S Brackenridge; N J Proudfoot
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Unpaired terminal nucleotides and 5' monophosphorylation govern 3' polyadenylation by Escherichia coli poly(A) polymerase I.

Authors:  Y Feng; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Isolation and characterization of polyadenylation complexes assembled in vitro.

Authors:  K L Veraldi; G Edwalds-Gilbert; C C MacDonald; A M Wallace; C Milcarek
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

5.  Complex protein interactions within the human polyadenylation machinery identify a novel component.

Authors:  Y Takagaki; J L Manley
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 6.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

7.  An uncapped RNA suggests a model for Caenorhabditis elegans polycistronic pre-mRNA processing.

Authors:  Yingmiao Liu; Scott Kuersten; Tao Huang; Alison Larsen; Margaret MacMorris; Thomas Blumenthal
Journal:  RNA       Date:  2003-06       Impact factor: 4.942

8.  Evidence that polyadenylation factor CPSF-73 is the mRNA 3' processing endonuclease.

Authors:  Kevin Ryan; Olga Calvo; James L Manley
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

9.  Secondary structure as a functional feature in the downstream region of mammalian polyadenylation signals.

Authors:  Chunxiao Wu; James C Alwine
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms.

Authors:  A Moreira; Y Takagaki; S Brackenridge; M Wollerton; J L Manley; N J Proudfoot
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.